Good afternoon, everyone, and welcome to our fourth quarter 2025 earnings call. Bob Bradway will lead the call today and be ...
Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With ...
Amgen believes that it can transcend the expected tradeoff between convenience and efficacy, anticipating that its investigational obesity drug MariTide will continue to provide competitive weight ...
Zacks Investment Research on MSN
AMGN's Q4 Earnings & Sales Beat Estimates, Obesity Candidate in Focus
Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of ...
Gadget Review on MSN
Gene editing breakthrough could end your daily cholesterol pills – here's what it means for you
CRISPR therapy STX-1150 could replace daily cholesterol pills with a single dose, reducing LDL by 50% for 18+ months using ...
A previous version of this story had an incorrect title for Brian Dunkin. He is the chief medical officer of endoscopy at Boston Scientific. The story has been corrected. Millions of Americans have ...
Slimmers who come off weight-loss injections such as Mounjaro or Wegovy can regain their lost pounds four times faster than those who stop conventional dieting and exercising, new research suggests.
TrumpRx is a government-run direct-to-consumer drug sale website. TrumpRx will launch in January 2026 A new government-run discount medicine website is set to launch this month. It's called TrumpRx: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results